National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

AG014699

 A substance being studied in the treatment of some types of cancer. It blocks enzymes that repair DNA damage caused by chemotherapy and radiation therapy. AG014699 is a type of poly(ADP-ribose) polymerase inhibitor. Also called PARP-1 inhibitor AG014699.



Previous Definitions:aflatoxin, aflibercept, AFP, AFP464, AG-013736
Next Definitions:AG2037, AG3340, AG337, agent study, agglutinin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov